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Abstract Pokeweed antiviral protein (PAP) inactivates both 
eukaryotic and prokaryotic ribosomes via a specific depurination 
of rRNA. The sensitivity of pokeweed ribosomes to PAP implies 
the existence of a mechanism to protect the plant. Using 
monoclonal antibodies specific to PAP, a protein complex 
(PAPi) which contained PAP was identified in leaf extract. In 
this complex, the enzymatic activity of the toxin was strongly 
inhibited. This protein complex had a p / lower than that of PAP 
and was separated from free PAP by a preparative native gel 
electrophoresis. PAPi had an apparent molecular mass of 57 
kDa and was dissociated by heating for 5 min at 80°C or by 
treatment by alkaline or acidic pH or by 7 M urea. The other 
components involved in the complex remain unknown. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Pokeweed antiviral Protein (PAP) is a type I ribosome in-
activating protein (RIP) isolated from the leaves of the plant 
Phytolacca americana (pokeweed). RIPs are R N A 7V-glycosi-
dases that catalyze the removal of a single adenine residue 
(adenine-4327) from a conserved loop of the 28S r R N A of 
eukaryotic ribosomes [1]. This depurination prevents the bind-
ing of the elongation factor EF-2 and therefore inhibits trans-
lation. This activity makes RIPs powerful inhibitors of protein 
synthesis. 
Other isoforms of PAP have been identified in P. ameri-
cana, PAP-S in seeds [2] and P A P II in summer leaves [3]. 
Although P A P seems to be constitutively synthesized, P A P II 
is found in leaves later in the growing season. 
P A P has been shown to inhibit infection by many different 
animal and plant viruses [4,5]. This property has been used to 
develop transgenic tobacco resistant to viral infection [6]. 
Ready et al. [7] showed that PAP was localized in the cell 
wall matrix. These authors suggested that the toxin could 
protect the plant from virus infection by penetrating into 
the cell together with the viruses and thus preventing viral 
replication by inhibiting protein biosynthesis. Recent evidence 
has indicated that internalization of PAP may be virus in-
duced [8]. Moreover, Bonness et al. [9] demonstrated that 
pokeweed ribosomes were sensitive to PAP. Local suicide 
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Abbreviations: mAb, monoclonal antibody; E40, pokeweed leaf 
extract after ammonium sulfate fractionation; PE extract, pokeweed 
leaf extract after preparative native gel electrophoresis; ND-PAGE, 
non-denaturing polyacrylamide gel electrophoresis 
may be particularly effective against mechanically transmitted 
viruses which require local wounding in order to enter cells. 
Since PAP has been shown to be effective on its own ribo-
somes, the toxin should be either spatially separated in a 
different cell compartment or temporally inhibited until it 
reaches the cell wall. The c D N A of P A P contains sequences 
encoding N- and C-terminal peptides which are absent in the 
mature protein [10], but these peptides do not inhibit enzy-
matic activity of recombinant PAP (Radom, personal commu-
nication). It can be thought that they could be involved in the 
targeting of PAP to the cell wall. 
This paper investigates the mechanism involved in the plant 
protection against its own toxin. Previously monoclonal anti-
bodies (mAb) highly specific to PAP were produced and char-
acterized [11]. These mAbs led to the identification of a minor 
form of PAP, present as a complex in a crude pokeweed leaf 
extract and showed that the toxin involved in this complex 
was strongly inhibited. 
2. Materials and methods 
2.1. Removal of free PAP from leaf extract by native preparative 
electrophoresis 
Frozen spring leaves (100 g) were pulverized in liquid nitrogen and 
homogenized in 300 ml of extraction buffer (3 mM DTT, 1 mM 
PMSF, 2 mM EDTA, 25 mM Tris-HCl, pH 7.5). After 20 min cen-
trifugation at 20000Xg (GSA type rotor, Sorvall) the supernatant 
was fractioned by ammonium sulfate between 40 and 100% of satu-
ration. The 100% pellet was resuspended in 25 ml of buffer containing 
25 mM Tris-HCl, pH 7.5, 50 mM NaCl, 0.2 mM EDTA, 2 mM DTT 
and desalted by gel filtration on a 2.5X60 cm Sephadex G10 column 
(Pharmacia) equilibrated with the same buffer. Then, proteins were 
concentrated by ultrafiltration to a final volume of 10 ml (AMICON 
cell, cut-off 10 kDa). This extract, called E40, was adjusted to 62.5 
mM Tris-HCl, pH 6.8, and 10% glycerol (sample buffer) and then 
loaded onto a non-denaturing polyacrylamide preparative gel electro-
phoresis prepared as follows. The glass column of the Bio-Rad model 
491 'Prep Cell System' (internal diameter: 57 mm) was filled with 30 
ml of a solution containing 4.5% acrylamide, 0.012% bis-acrylamide, 
125 mM Tris-HCl, pH 6.8. Polymerization was catalysed with ammo-
nium persulfate and TEMED. Electrophoresis was performed at 10 W 
constant power in the migration buffer (25 mM Tris-HCl, 192 mM 
glycine, pH 8.3). Elution was performed at a flow rate of 0.5 ml/min 
and 3 ml fractions were collected. The presence of free PAP and 
complexed PAP was then checked in eluted fractions by ND-PAGE 
and Western blotting. The obtained fraction was called the PE ex-
tract. 
2.2. Double sandwich ELISA 
Microplates were coated for 2 h at 37°C with 100 ul of anti-PAP 
purified polyclonal antibodies (3 u.g/ml) in a 50 mM carbonate buffer, 
pH 9.6. After washing, wells were saturated with 1% PBS-BSA for 2 h 
at 37°C. Subsequently, 100 ul of diluted PE extract were incubated for 
1 h at room temperature under gentle shaking. Then, wells were in-
cubated for 1 h at room temperature with mAb 7.1E5 (0.3 u.g/ml) [11] 
mixed with diluted anti-mouse peroxidase-labeled antibodies (1:2000, 
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Biosys). Enzymatic activity was measured by incubation for 10 min 
with a commercial solution of 3,3',5,5'-tetramethylbenzidine (TMB) 
and H2O2 as substrates. The reaction was stopped by the addition of 
50 ul of 2 N HC1 and absorbance was measured at 450 nm with a 
microplate reader. 
2.3. Analytical electrophoresis and immunoblotting 
Proteins were separated under denaturing conditions by SDS-
PAGE according to Laemmli [12] or under non-denaturing conditions 
according to Blackhear [13]. Briefly, the native gel electrophoresis 
consisted of a separating gel at 11% acrylamide, pH 8.8, and a stack-
ing gel at 4.5% acrylamide, pH 6.8, without SDS. The sample buffer 
was the Laemmli sample buffer, but it contained neither SDS nor p-
mercaptoethanol. After migration, gels were transferred to a PVDF 
membrane using a Bio-Rad trans-blot apparatus in 25 mM Tris-HCl, 
192 mM glycine, 0.02% SDS and 10% methanol. Immunoblotting 
analysis was performed as previously described [11]. 
2.4. In vitro translation assay 
Different amounts of PE extract and purified PAP, native or heat 
treated for 5 min at 80°C (2 ul each) were added to the translation 
mixture containing 4 ul of rabbit reticulocyte lysate (Promega), 0.2 jj.1 
of a mixture of the different amino acids (minus methionine) at a 
concentration of 1 mM, 0.2 ul of L-[35S]methionine (3.10s Bq/ml, 
DuPont), 5.2 ul of H2O. The reaction was started by the addition 
of 0.2 JJ,1 of a stock solution of Brome mosaic virus (BMV) RNA at 
0.5 mg/ml. After incubation (1 h at 30°C), 2 ul aliquots of each assay 
were analyzed by SDS-PAGE and the gel was then autoradiographed. 
Densitometric analysis of the band at 35 kDa encoded by BMV RNA 
was performed with the Bio-Rad 'gel-Doc' system. 
3. Results 
3.1. Detection of the complexed PAP by non-denaturing 
electrophoresis 
Proteins from a pokeweed leaf extract (E40) were separated 
by non-denaturing gel electrophoresis including a stacking gel 
at pH 6.8 and a separating gel at pH 8.8. At pH 6.8, PAP was 
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Fig. 1. Analysis of proteins from E40 extract (50 ug for each lane) 
by Western blotting after ND-PAGE. Proteins were detected with a 
mixture of mAbs (1.3B5, 2.5H2, 6.1C8 and 7.1E5) as described in 
Section 2. Lane 1: E40 extract heated for 5 min at 80°C prior to 
electrophoresis; lane 2: non-heated E40 extract; lane 3: 5 ug of pu-
rified PAP as control. 
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Fig. 2. Detection and quantification of PAP in PE extract by double 
sandwich ELISA. Wells were coated with purified anti-PAP polyclo-
nal antibody (3 ug/ml) and saturated with 1% PBS-BSA. PE extract 
was then incubated at different dilutions before (□) or after (■) heat 
denaturation for 5 min at 80°C. The ELISA protocol is described in 
Section 2. The absorbance value corresponding to 1:900 and 1:2700 
dilution factor were used for estimating the concentration of PAP in 
the PE extract with reference to a standard curve established with 
heat-treated purified PAP. Each value was the average of three as-
says with the same PE extract. 
protonated and migrated toward the cathode and not into the 
gel. Nevertheless, Western blotting analysis using a mixture of 
different monoclonal antibodies specific to PAP revealed an 
immunoreactive component (Fig. 1, lane 2). This band was 
not detected when the sample was heated for 5 min at 80°C 
prior to loading onto the electrophoresis gel (lane 1). As ex-
pected, no band was detected in the control lane where puri-
fied PAP was loaded (lane 3) indicating that electrophoresis 
conditions did not allow its migration into the gel. 
These results indicate that the leaf extract contains another 
protein or a protein complex detected by the anti-PAP mAbs. 
The identified component was called PAPi. In order to per-
form preliminary characterization, an extract containing PAPi 
but devoid of free PAP was prepared. As indicated above, pH 
6.8 of the stacking gel electrophoresis could separate both 
PAP and PAPi entities. Thus, a simple non-denaturing prep-
arative gel electrophoresis consisting of a 4.5% polyacrylamide 
gel at pH 6.8 was developed. Non-denaturing gel electropho-
resis and Western blotting analysis performed on the eluted 
fraction (PE extract), confirmed the presence of PAPi (data 
not shown). 
3.2. ELISA detection and quantification of PAP in PE extract 
A sandwich ELISA had been previously developed in our 
laboratory to quantify PAP in plant extracts (unpublished 
results). In this assay the antigen was trapped between a 
coated polyclonal antibodies and the mAb 7.1E5 [11] which 
was known to react with a recombinant peptide including the 
63 C-terminal amino acids of mature PAP [14]. Fig. 2 shows 
the ELISA response versus increasing dilutions of either na-
tive or heat-treated PE extract. No PAP could be detected in 
the untreated sample while the same sample, heated for 5 min 
at 80°C, gave a strong ELISA response. Using a standard 
curve established with heat-treated purified PAP as reference, 
PAP concentration in the heat-treated PE extract was esti-
mated at 12 (ig/ml. These results indicated that the mAb 
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Fig. 3. Effect of different treatments on the stability of PAPi. A: Effect of temperature: PE extract was heated at 80 °C for increasing incuba-
tion times and then diluted in PBS and tested by ELISA. B: Effect of pH: A PE extract fraction was equilibrated with various buffers with a 
pH ranging from 2.8 to 9.6. After 1 h incubation, samples were re-equilibrated at pH 7.4 by dilution in PBS buffer and then tested by ELISA. 
C: Effect of urea: PE extracts were incubated with increasing concentrations of urea ranging from 2 to 7 M for 2 h at room temperature. 
Then samples were diluted with PBS and were immediately tested by the sandwich ELISA as described in Section 2. PAP was quantified as in 
Fig. 2. The amounts of PAP were calculated on the basis of a PAP standard curve. Each value is the average of three assays with the same 
PE extract. 
7.1E5 epitope was not accessible in PAPi. Thus, PAPi could 
be a complex involving PAP and an unknown protein. This 
double sandwich ELISA proved to be a very reliable criterium 
for the determination of PAPi integrity since PAP was de-
tected only after dissociation of the complex. 
3.3. Preliminary characterization of the PAPi complex 
The stability of the complex in relation to different denatur-
ing agents such as temperature, pH and urea was investigated. 
The effect of the different treatments was evaluated by the 
quantification of the resulting PAP released from the complex 
and thus was monitored by the double sandwich ELISA tech-
nique. 
3.3.1. Effect of temperature. The PE extract was incubated 
for various periods of time at 80°C and then tested by ELISA. 
Fig. 3A shows that a maximal quantity of PAP was released 
from the complex after a treatment of 5 min. 
3.3.2. Effect of pH. The equilibration of the PE extract in 
buffers at different pHs ranging from 2.8 to 9.5 showed that 
PAPi was stable between pH 6 and 8, but was dissociated at 
alkaline or acidic pHs (Fig. 3B). 
3.3.3. Effect of urea. PE fractions were equilibrated with 
increasing concentrations of urea ranging from 2 to 7 M and 
incubated for 2 h at room temperature. Then, the fractions 
were diluted in PBS buffer and tested by ELISA. Fig. 3C 
shows the effect of urea concentration on the PAPi complex. 
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Fig. 4. Refolding of PAPi after denaturation by 7 M urea. Proteins from PE extract were equilibrated with 7 M urea as described in Fig. 3C 
and assayed by ELISA at various dilutions (■). Samples were then diluted 20-fold in the refolding buffer (50 mM NaCl, 50 mM Tris-HCl, pH 
8), incubated under gentle shaking overnight at 4°C and tested by sandwich ELISA at various dilutions (□). Inset: The same samples were con-
centrated 20-fold by ultraflltration (Amicon, cut-off 10 kDa) and analyzed by Western blotting after ND-PAGE with 1:1000 dilution of mAb 
1.3B5 and 6.1C8. Lane 1: native PE extract; lane 2: PE extract denatured by 7 M urea; lane 3: PE extract after refolding. 
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Fig. 5. A: Molecular mass determination of PAPi by Western blotting analysis. PE extract proteins (20 u.g) were separated by SDS-PAGE 
(12.5% acrylamide) and transferred to a PVDF membrane. Immunodetection was performed with a mixture of mAb 1.3B5 and 6.1C8 (dilution 
factor: 1:1000). Lane 1: 0.5 (ig of purified PAP; lane 2: PE extract heated for 5 min at 80°C prior to electrophoresis; lane 3: unheated PE ex-
tract. B: Two-dimensional electrophoresis analysis of PE extract. PE extract was first run on a ND-PAGE and the corresponding lane of poly-
acrylamide was cut and loaded on the top of a SDS-polyacrylamide gel. Then the resulting gel was transferred for Western-blotting analysis us-
ing the mAb 1.3B5 and 6.1C8 at 1:1000 dilution. 
Concentrations below 4 M had no effect on its stability while 
PAP was progressively released from the PAPi complex at 
concentrations above 4 M. The maximal release was observed 
at 7 M urea. Purified PAP treated under the different condi-
tions (temperature, pH and urea) and assayed by ELISA re-
acted in the same way as native PAP (data not shown). 
Renaturation of the PAPi complex after urea treatment was 
performed by dilution of the denatured proteins in a refolding 
buffer (50 mM NaCl, 50 mM Tris-HCl, pH 8). Analysis of the 
denatured and renatured proteins performed by ELISA 
showed that the two curves exhibited similar features indicat-
ing that the quantity of PAP in both samples could be corn-
Table 1 
Biological activity of PAPi on in vitro protein synthesis in a rabbit 
reticulocyte system 
PAPng/mla 
50 
20 
10 
5 
Rate of translation 
Complexed PAP 
(nh) 
26 
34 
63 
nt 
(h) 
< 5 
8 
15 
nt 
(%) 
Purified PAP 
(nh) 
< 5 
< 5 
9 
11 
(h) 
< 5 
< 5 
18 
42 
Equivalent amounts of purified PAP and complexed PAP from PE 
extract either heated for 5 min at 80°C (h) or not (nh) were added to 
the translation mixture as described in Section 2. Results were nor-
malized to controls obtained in the absence of PAP and PAPi (100%) 
and in the absence of BMV-RNA template (0%). Values represent the 
average from duplicate sample. These results were reproduced 5 times 
with different preparations of PE extract and the nh/h ratio continued 
to range from 3 to 4. 
"Amounts of PAP were determined by ELISA on heat-treated PE 
extract and heat-treated PAP. 
nt: non-tested. 
pared (Fig. 4). Free PAP concentrations were estimated at 
11.5 |J.g/ml and 4.5 (J-g/ml in the denatured and renatured 
samples respectively indicating that the complex was refolded 
at 60%. The Western blot (inset Fig. 4) confirmed these re-
sults. PAPi was not revealed when the sample was incubated 
in 7 M urea (lane 2), indicating the complex dissociation. 
After refolding, two neighboring bands were detected (lane 
3). These two bands indicate that PAPi was probably refolded 
into two different spatial conformations. 
3.4. Estimation of the molecular mass of the PAPi complex 
The molecular mass of PAPi was estimated by SDS-PAGE 
according to Laemmli [12] and Western blotting, except that 
the sample was not heated prior to electrophoresis in order to 
avoid the dissociation of subunits. As shown in Fig. 5A, lane 
3, the PAPi complex was resistant to SDS and had an ap-
parent molecular mass of 57 kDa. After heat treatment (Fig. 
5A, lane 2) the complex was dissociated and PAP was de-
tected by monoclonal antibodies at 29 kDa in the same way 
as the control performed with purified PAP (lane 1). A two-
dimensional electrophoresis was performed in order to con-
firm that the 57 kDa protein and those detected after ND-
PAGE were indeed the same. In the first dimension, proteins 
from PE extract were separated by ND-PAGE and in the 
second by SDS-PAGE. The proteins were then analyzed by 
Western blotting using a mixture of mAbs. Fig. 5B shows a 
single spot at 57 kDa indicating that the band detected ini-
tially after ND-PAGE corresponded to the band detected by 
SDS-PAGE. These experiments showed that the complex was 
resistant to a 2% concentration of SDS as well as to (i-mer-
captoethanol, thus indicating that no disulfide bond was in-
volved in the quaternary structure. 
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3.5. Comparison of the PAPi biological activity before and 
after denaturation 
The biological activity of PAPi was investigated with an in 
vitro translation system. The PAP contained in the PAPi frac-
tion was first quantified by ELISA after its release from the 
complex by heat treatment. Table 1 compares the residual rate 
of translation obtained in the presence of equivalent concen-
trations of PAPi and purified PAP, either native or heat 
treated. In all cases the translation rate was reduced by a 
factor around 4 when the PE extract was heated prior to its 
addition to the translation mixture. Moreover, when PAPi 
was dissociated the translation rates were comparable to those 
obtained with the same quantities of heat treated purified 
PAP. PAP is known to be a temperature resistant protein 
[15]. However, the activity of native and heat treated purified 
PAP was compared. Table 1 shows that the treatment slightly 
decreased the enzymatic activity of the toxin indicating that a 
minor fraction of the toxin was denatured. This would suggest 
that the inhibition of the biological activity of PAP in PAPi 
could have been underestimated. These results clearly indicate 
that the biological activity of the toxin is strongly reduced in 
PAPi and that its thermal denaturation induced a release of 
enzymatically active PAP. 
4. Discussion 
Bound ribosomes synthesize the toxin which is then tar-
geted to the cell wall through the endoplasmic reticulum 
and the golgi apparatus. Nevertheless, it could be thought 
that a few PAP molecules could escape this pathway and, 
considering the high toxicity of PAP, kill the cell. Bonness 
et al. [9] have already suggested the existence of a protective 
element able to take over the free PAP molecules in the cyto-
plasm, but were unsuccessful in finding it. Since these authors 
worked with a PAP free cell line, they could not definitively 
exclude the existence of such a protective element because its 
expression could be correlated with that of PAP. Our experi-
ments attempted to find this inhibitor in pokeweed leaf cells. 
The hypothesis was that if such an inhibitor existed it would 
be found in plant extract as a complex with PAP. Then, the pi 
of the complex would be different and probably lower than 
that of PAP which is 8.1 [16]. Thus, a native PAGE was 
developed under pH conditions that did not allow free PAP 
to migrate into the gel. Western blotting analysis using specific 
mAb did detect a minor form of PAP that proved to be in-
volved in a complex showing a lower pi. These analyses were 
performed with a mixture of mAbs in order to avoid any 
problem of detection due to hidden PAP epitopes in PAPi. 
Further Western blotting analysis after SDS-PAGE and ELI-
SA showed that this complex was dissociated by different 
chemical or physical treatments to release free PAP. The 
urea treatment appeared reversible. The possibility of refold-
ing PAPi represented an additional argument to demonstrate 
that PAP was associated by non-covalent interactions with 
another uncharacterized component. The ELISA emphasized 
the role of the C-terminus domain of PAP in the complex. 
mAb 7.1E5 whose epitope had been identified in the C-termi-
nal domain was not able to bind to PAP in the complex. It 
can be concluded that the mAb 7.1E5 epitope is hidden in the 
complex because the association of PAP and its partner im-
plies at least a part of this domain. 
Hur et al. [17] have recently described and characterized 
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PAP mutants in a yeast expression system. Mutants with a 
deletion of 25 amino acyl residues at the C-terminus were 
enzymatically active in vitro, but non-toxic to yeast in vivo. 
These results suggest that PAP cytotoxicity is not due solely 
to its enzymatic activity. Moreover, the C-terminal extremity 
of PAP was shown to be homologous to the consensus se-
quence for a prokaryotic lipid binding site which could facil-
itate the passage across membranes. Chaudhary et al. [18] 
have shown that removal of the C-terminal sequence of Pseu-
domonas aeruginosa exotoxin A strongly reduced its toxicity 
without affecting its enzymatic activity. This evidence strongly 
supports the physiological importance of this domain and 
gives relevance to our data. 
It has been demonstrated that the RIP activity of the native 
PAPi complex was strongly reduced. PAP molecules involved 
in the complex were inhibited, but they could be released as 
enzymatically active molecules by heat treatment. Neverthe-
less, complexed PAP represented only a minor part of the 
toxin in comparison with the high amount of PAP present 
in the cell. 
The apparent molecular mass of PAPi was estimated at 57 
kDa. So far, the other component involved in this complex 
has not been characterized. PAPi could also result from a 
dimerization of PAP, although experiments of spontaneous 
dimerization of purified PAP have still not been successful. 
A dimeric form of oc-sarcin, a RIP with a ribonuclease activ-
ity, has been identified in a purified toxin preparation [19]. 
Recently, these dimers have been shown to be inactive and 
it has been suggested that a dimer formation could play a 
biological role in preventing the cytotoxicity of a-sarcin [20]. 
Nevertheless, the existence of an unknown protein associated 
to PAP in a heterodimer cannot be excluded. Experiments 
should be oriented now to complete the biochemical charac-
terization of PAPi. Further purification of PAPi is being 
undertaken and involves an affinity chromatography step. 
The purification should be able to identify the protein com-
position of the complex. 
The physiological relevance of these data, now, needs to be 
proven in vivo in order to be able to propose this complex as 
a mechanism developed by pokeweed to protect itself from the 
toxicity of this toxin. 
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